Apathy associated with Alzheimer disease: use of dextroamphetamine challenge.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  The American journal of geriatric psychiatry

• Publication date

  2008-07-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1097/JGP.0b013e318170a6d1PMID 18591575
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neuroanatomical characteristics of geriatric apathy and depression: a magnetic resonance imaging study.

  2007cited by this paper
• A SPECT Study of Apathy in Alzheimer’s Disease

  2007influential reference
• Subjective and behavioural consequences of striatal dopamine depletion in schizophrenia--findings from an in vivo SPECT study.

  2006cited by this paper
• The contribution of neuropsychiatric symptoms to the cost of dementia care

  2006cited by this paper
• Selective serotonin reuptake inhibitor use associates with apathy among depressed elderly: a case-control study

  2006cited by this paper
• The mesolimbic dopamine reward circuit in depression.

  2006cited by this paper
• Effects of donepezil on neuropsychiatric symptoms in patients with dementia and severe behavioral disorders.

  2006cited by this paper
• Quality of life in dementia: more than just cognition. An analysis of associations with quality of life in dementia

  2006cited by this paper
• Selective serotonin reuptake inhibitor use associates with apathy among depressed elderly: a case-control study

  2006cited by this paper
• Functional neuroanatomical substrates of altered reward processing in major depressive disorder revealed by a dopaminergic probe.

  2005cited by this paper
• Alcohol dependence is associated with blunted dopamine transmission in the ventral striatum.

  2005cited by this paper
• Oral D‐amphetamine causes prolonged displacement of [11C]raclopride as measured by PET

  2004cited by this paper
• Presynaptic nigro-striatal function in a group of Alzheimer’s disease patients with parkinsonism: evidence from a dopamine transporter imaging study

  2004cited by this paper
• Differential dose-response effects of dexamphetamine sulphate on hunger, arousal and mood in human volunteers

  2004cited by this paper
• Bupropion in the management of apathy

  2004cited by this paper
• Predictors of institutionalisation in people with dementia

  2003cited by this paper
• Executive dysfunction and apathy predict functional impairment in Alzheimer disease.

  2003cited by this paper
• Decreased striatal D2 receptor density associated with severe behavioral abnormality in Alzheimer’s disease

  2003cited by this paper
• Apathy syndrome in cocaine dependence.

  2002cited by this paper
• Acute Administration of d-Amphetamine Decreases Impulsivity in Healthy Volunteers

  2002cited by this paper
• Probing brain reward system function in major depressive disorder: altered response to dextroamphetamine.

  2002cited by this paper
• Differentiation of dementia with Lewy bodies from Alzheimer's disease using a dopaminergic presynaptic ligand

  2002cited by this paper
• Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria.

  2001influential reference
• Conners' Continuous Performance Test II (CPT II) Computer Program for Windows, Technical Guide and Software Manual

  2000cited by this paper
• Improvement of sleep and behavior by methylphenidate in Alzheimer's disease.

  1999cited by this paper
• Reinforcing effects of psychostimulants in humans are associated with increases in brain dopamine and occupancy of D(2) receptors.

  1999influential reference
• The spectrum of behavioral responses to cholinesterase inhibitor therapy in Alzheimer disease.

  1999cited by this paper
• Methylphenidate treatment of negative symptoms in patients with dementia.

  1997cited by this paper
• BEHAVIOUR DISTURBANCE AND OTHER PREDICTORS OF CARER BURDEN IN ALZHEIMER'S DISEASE

  1997cited by this paper
• Insulin-like growth factor I, insulin-like growth factor binding proteins, and growth hormone binding protein in Spanish premature and full-term newborns.

  1996cited by this paper
• PET evaluation of the dopamine system of the human brain.

  1996cited by this paper
• Hedonic valence, dopamine and motivation.

  1996cited by this paper
• The spectrum of behavioral changes in Alzheimer's disease

  1996cited by this paper
• Reduced striatal dopamine receptors in Alzheimer's disease

  1996cited by this paper
• SPECT imaging of striatal dopamine release after amphetamine challenge.

  1995cited by this paper
• Damage to dopamine systems differs between parkinson's disease and alzheimer's disease with parkinsonism

  1995cited by this paper
• The Neuropsychiatric Inventory

  1994cited by this paper
• Determination of amphetamine, methamphetamine and desmethyldeprenyl in human plasma by gas chromatography/negative ion chemical ionization mass spectrometry.

  1993cited by this paper
• Monoamine neurotransmitters and their metabolites in brain regions in alzheimer's disease: A postmortem study

  1992cited by this paper
• Reliability and validity of the Apathy Evaluation Scale.

  1991influential reference
• Apathy: a neuropsychiatric syndrome.

  1991cited by this paper
• Major depression in Parkinson's disease and the mood response to intravenous methylphenidate: possible role of the "hedonic" dopamine synapse.

  1989cited by this paper
• Clinical diagnosis of Alzheimer's disease

  1984cited by this paper
• Changes of Biogenic Amines and Their Metabolites in Postmortem Brains from Patients with Alzheimer‐Type Dementia

  1984cited by this paper
• “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician

  1975cited by this paper
• Simultaneous quantification of homovanillic acid and 5-hydroxyindoleacetic acid in cerebrospinal fluid by mass fragmentography.

  1974cited by this paper
• Profile of mood states

  1971cited by this paper
• The Addiction Research Center Inventory: Standardization of scales which evaluate subjective effects of morphine, amphetamine, pentobarbital, alcohol, LSD-25, pyrahexyl and chlorpromazine

  1963cited by this paper

• Apathy in Neuropsychiatric Disorders: Clinical Characteristics, Neurobiological Mechanisms, and Therapeutic Strategies

  2025cites this paper
• Advances in Brain Stimulation, Nanomedicine and the Use of Magnetoelectric Nanoparticles: Dopaminergic Alterations and Their Role in Neurodegeneration and Drug Addiction

  2024cites this paper
• Apathy Associated with Alzheimer's Disease

  2024cites this paper
• Elevated plasma total homocysteine levels are associated with behavioral and psychological symptoms in dementia with Lewy bodies

  2024cites this paper
• Biomedical knowledge graph learning for drug repurposing by extending guilt-by-association to multiple layers

  2023cites this paper
• An Update on Apathy in Alzheimer’s Disease

  2023cites this paper
• Apathy in Parkinson’s Disease: Defining the Park Apathy Subtype

  2022cites this paper
• Diagnostic criteria for apathy in neurocognitive disorders

  2021cites this paper
• The link between apathy and Alzheimer’s Disease: The role of psychometric tools and the possible implications for treatment

  2021cites this paper
• Norepinephrine May Oppose Other Neuromodulators to Impact Alzheimer’s Disease

  2021cites this paper
• Efficacy and Safety of Psychostimulants for Alzheimer’s Disease: A Systematic Review and Meta-Analysis

  2020cites this paper
• A cross sectional study

  2020cites this paper
• Selective serotonin reuptake inhibitors-associated apathy syndrome

  2020cites this paper
• Novel Pharmacologic Strategies for Treating Behavioral Disturbances in Alzheimer’s Disease

  2019cites this paper
• Exposure to ambient fine particles and neuropsychiatric symptoms in cognitive disorder: A repeated measure analysis from the CREDOS (Clinical Research Center for Dementia of South Korea) study.

  2019cites this paper
• Neurobiology of Positive Emotion Disruption in Neurodegenerative Disease

  2019cites this paper
• The Roles of Apathy and Depression in Predicting Alzheimer Disease: A Longitudinal Analysis in Older Adults With Mild Cognitive Impairment.

  2019cites this paper
• Dopamine and Dopamine Receptors in Alzheimer's Disease: A Systematic Review and Network Meta-Analysis

  2019cites this paper
• Behavioral and psychological symptoms in Alzheimer's dementia and vascular dementia.

  2019cites this paper
• Adding Methylphenidate to Address Apathy in Dementia-Insights from Case Reports

  2018cites this paper
• The Apathy in Dementia Methylphenidate Trial 2 (ADMET 2): study protocol for a randomized controlled trial

  2018cites this paper
• Apathy associated with neurocognitive disorders: Recent progress and future directions

  2017cites this paper
• Visual Scanning and Attentional Biases in Alzheimerâ s Disease: Assessing Symptoms and Outcomes

  2017cites this paper
• Pharmacological Therapy for Apathy in Alzheimer’s Disease: A Systematic Review and Meta-Analysis

  2017cites this paper
• Classification of Neuropsychiatric Symptoms Requiring Antipsychotic Treatment in Patients with Alzheimer’s Disease: Analysis of the CATIE-AD Study

  2016cites this paper
• Drug Development in Alzheimer’s Disease: The Contribution of PET and SPECT

  2016cites this paper
• Visual Selective Attention Toward Novel Stimuli Predicts Cognitive Decline in Alzheimer’s Disease Patients

  2016cites this paper
• Reward processing in neurodegenerative disease

  2015cites this paper
• Principles and management of neuropsychiatric symptoms in Alzheimer’s dementia

  2015cites this paper
• Neurotransmitters and Memory

  2014cites this paper
• Serum homocysteine levels are correlated with behavioral and psychological symptoms of Alzheimer’s disease

  2014cites this paper
• Neuroplasticity, neurotransmitters and new directions for treatment of anomia in Alzheimer disease

  2014cites this paper
• Safety and efficacy of methylphenidate for apathy in Alzheimer's disease: a randomized, placebo-controlled trial.

  2013cites this paper
• Effect of Methylphenidate on Attention in Apathetic Alzheimer’s Disease Patients and Association with Apathy Changes in a Randomized, Placebo-controlled Trial

  2013cites this paper
• Effect of methylphenidate on attention in apathetic AD patients in a randomized, placebo-controlled trial

  2013cites this paper
• Apathy Syndrome in Alzheimer's Disease Epidemiology: Prevalence, Incidence, Persistence, and Risk and Mortality Factors

  2012cites this paper
• NF-κB knockdown can modulate amphetamine-mediated feeding response.

  2012cites this paper
• Apathy: a separate syndrome from depression in dementia? A critical review

  2012cites this paper
• The Role of Dopamine in Symptoms and Treatment of Apathy in Alzheimer's Disease

  2011cites this paper
• Knocking down the transcript of protein kinase C-lambda modulates hypothalamic glutathione peroxidase, melanocortin receptor and neuropeptide Y gene expression in amphetamine-treated rats

  2011cites this paper
• PLASMA HOMOCYSTEINE LEVEL AND APATHY IN ALZHEIMER'S DISEASE

  2011cites this paper
• Neuropsychiatric symptoms in Alzheimer's disease

  2011cites this paper
• Chapter 136 – Sleep in Independently Living and Institutionalized Elderly

  2011cites this paper
• Dissociating behavioral disorders in early dementia-An FDG-PET study.

  2011cites this paper
• COGNITIVE RESERVE, HOMOCYSTEINE, AND COGNITION IN THE BAVARIAN SCHOOL SISTERS STUDY

  2011cites this paper
• Perspectives Neuropsychiatric symptoms in Alzheimer's disease

  2011cites this paper
• Sintomatología neuropsiquiátrica y conductual en la enfermedad de

  2010cites this paper
• [Neuropsychiatric and behavioral symptomatology in Alzheimer disease].

  2010cites this paper
• Use of Psychostimulants in Patients with Dementia

  2010cites this paper
• Blastomicosis prostática: presentación de un caso y revisión de la literatura

  2010cites this paper
• Current awareness in human psychopharmacology.

  2009cites this paper
• Neuropsychiatric symptoms in Alzheimer disease and related disorders: why do treatments work in clinical practice but not in the randomized trials?

  2008cites this paper
• Commentary: Abeta(1-42) injection causes memory impairment, lowered cortical and serum BDNF levels, and decreased hippocampal 5-HT2A levels.

  2008cites this paper
• Current awareness in human psychopharmacology

  2008cites this paper